Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEvommune Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.94 | -$0.62 | -$0.81 |
| Q2 2026 | 7 | -$1.18 | -$0.48 | -$0.66 |
| Q3 2026 | 6 | -$1.19 | -$0.53 | -$0.68 |
| Q4 2026 | 4 | -$0.72 | -$0.72 | -$0.72 |
| Q1 2027 | 2 | -$0.72 | -$0.72 | -$0.72 |
| Q2 2027 | 2 | -$0.76 | -$0.76 | -$0.76 |
| Q3 2027 | 2 | -$0.81 | -$0.81 | -$0.81 |
| Q4 2027 | 2 | -$0.85 | -$0.85 | -$0.85 |
| Q1 2028 | 3 | -$0.81 | -$0.81 | -$0.81 |
| Q2 2028 | 3 | -$0.82 | -$0.82 | -$0.82 |
| Q3 2028 | 3 | -$0.89 | -$0.89 | -$0.89 |
| Q4 2028 | 3 | -$0.88 | -$0.88 | -$0.88 |
Evommune Inc. Earnings Date And Information
Evommune Inc. last posted its earnings results on Thursday, May 7th, 2026. The company reported $-0.64 earnings per share for the quarter, topping analysts' consensus estimates of $-0.83 by $0.19. The company had revenue of 0 for the quarter and had revenue of 13.00 M for the year. Evommune Inc. has generated $-2 earnings per share over the last year ($-2.18 diluted earnings per share) and currently has a price-to-earnings ratio of -10.05. Evommune Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Evommune Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q1 2026 | N/A | -$0.64 | N/A | $722.17 K | $0 |
| 03/27/2026 | Q4 2025 | N/A | -$0.90 | N/A | $0 | $0 |
| 12/15/2025 | Q3 2025 | N/A | -$0.40 | N/A | $3.33 M | $10.00 M |
| 06/29/2025 | Q2 2025 | N/A | -$0.45 | N/A | N/A | $0 |
| 03/30/2025 | Q1 2025 | N/A | -$0.48 | N/A | N/A | $3.00 M |
| 12/31/2024 | Q4 2024 | N/A | -$0.63 | N/A | N/A | $0 |
| 06/29/2024 | Q2 2024 | N/A | -$0.91 | N/A | N/A | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$0.09 | N/A | N/A | $7.00 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Evommune Inc. Earnings: FAQ's
In the previous quarter, Evommune Inc. (:EVMN) reported $-0.64 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.83 by $0.19.
The conference call for Evommune Inc.'s latest earnings report can be listened to online.
The conference call transcript for Evommune Inc.'s latest earnings report can be read online.
Evommune Inc. (:EVMN) has a recorded annual revenue of $13.00 M.
Evommune Inc. (:EVMN) has a recorded net income of $-68,870,000.Evommune Inc. has generated $-2.18 earnings per share over the last four quarters.
Evommune Inc. (:EVMN) has a price-to-earnings ratio of -10.05 and price/earnings-to-growth ratio is -0.76.